Synapse - David Kelsen

Results (537)

EGFR and MET amplifications determine response to HER2 inhibition in ERBB2-amplified esophagogastric cancer

Journal Article

Sanchez-Vega, F.; Hechtman, J. F.; Castel, P.; Ku, G. Y.; Tuvy, Y.; Won, H.; Fong, C. J.; Bouvier, N.; Nanjangud, G. J.; Soong, J.; more...
Cancer Discovery (2019)

Fulltext@MSK | Save

Outcomes for matched patients with metastatic colitis-associated cancers versus sporadic colorectal cancer receiving chemotherapy

Meeting Abstract

Yaeger, R.; Hersch, J.; Bates, D.; Paroder, V.; Chou, J. F.; Tang, L. H.; Gollub, M. J.; Capanu, M.; Kelsen, D. P.
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Detection of germline homologous recombination deficiency (HRD) in patients with metastatic esophagogastric (EG) cancer using clinical next generation sequencing (NGS)

Meeting Abstract

Janjigian, Y. Y.; Jonsson, P.; Kemel, Y.; Joseph, V.; Tuvy, Y.; Shameer, Z.; Ravichandran, V.; Zhang, L. Y.; Mandelker, D.; Ku, G. Y.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

PET scan-directed chemoradiation (CRT) for esophageal squamous cell carcinoma (ESCC): No benefit for salvage chemo in PET non-responders (PETnr)

Meeting Abstract

Greally, M.; Chou, J. F.; Molena, D.; Rusch, V. W.; Bains, M. S.; Park, B. J.; Wu, A. J. C.; Kelsen, D. P.; Janjigian, Y. Y.; Ilson, D. H.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Tumor mutation burden (TMB) and immune- related adverse events (irAEs) compared to antibiotic (abx) use to predict for response to immune checkpoint inhibitors in esophagogastric cancer (EGC)

Meeting Abstract

Greally, M.; Chatila, W. K.; Margolis, M.; Hechtman, J. F.; Tuvy, Y.; Kundra, R.; Ladanyi, M.; Kelsen, D. P.; Ilson, D. H.; Berger, M. F.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Plasma KRAS as a biomarker for pancreatic ductal adenocarcinoma (PDAC)

Meeting Abstract

Krantz, B. A.; Tsui, D.; Lowery, M. A.; Capanu, M.; Yu, K. H.; Kelsen, D. P.; Gedvilaite, E.; Zhang, L.; Selcuklu, S. D.; You, D.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Phase Ib/II trial of durvalumab and chemoradiation (CRT) with carboplatin/paclitaxel for esophageal and gastroesophageal junction (GEJ) adenocarcinoma

Meeting Abstract

Greally, M.; Molena, D.; Sihag, S.; Wu, A. J. C.; Shah, P. M.; Fein, C.; Capanu, M.; Kelsen, D. P.; Janjigian, Y. Y.; Ilson, D. H.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Targeted next-generation sequencing (NGS) of germline DNA to identify genetic predisposition to gastric cancer (GC) in patients with CDH1-mutation negative early-onset (EO) or familial GC (FGC)